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Introduction: An (inter)national systematic approach for patients with asthma COPD referred 
to secondary care is lacking. Therefore, a novel systematic approach was designed and tested 
in clinical practice.
Methods: This was a retrospective observational study of data from the electronic record 
system of the Leiden University Medical Center. Asthma and COPD patients were included if 
they were evaluated with a novel systematic approach or if they had a new record for asthma 
or COPD and received usual care. The novel systematic approach consisted of a predefined 
diagnostic evaluation combined with an optional internet-based self-management support 
system. Diagnostic tests, final diagnosis, lifestyle advices, symptoms and individual care plans 
in the electronic records, number of patients referred back to primary care, and time to referral 
back to primary care were compared between the systematic approach and usual care groups 
using t-tests and chi-squared tests.
Results: A total of 125 patients were included, of which 22 (21.4%) were evaluated with 
the systematic approach. Mean (±SD) age was 48.8 (±18.4) years and 59.2% were women. 
Mean (±SD) number of diagnostic tests was higher in the systematic approach group compared 
with the usual care group (7.6±1.0 vs 5.5±1.8, P,0.001). Similarly, in the systematic approach 
group, more lifestyle advices (81.8% vs 29.1%), symptom scores (95.5% vs 21.4%), and indi-
vidual care plans (50.0% vs 7.8%) were electronically recorded (P,0.001), and more patients 
were referred back to primary care (81.8% vs 56.3%, P=0.03). There were no differences in 
the final diagnoses and time to referral back.
Conclusion: Our study suggested that not all tests that were included in the systematic approach 
are regularly needed in the diagnostic work-up. In addition, a designated systematic approach 
stimulates physicians to record lifestyle advices, symptoms, and individual care plans. Thus, 
this approach could increase the number of patients referred back to primary care.
Keywords: asthma, COPD, diagnostics, eHealth, outpatient clinic, systematic approach
Introduction
Asthma and COPD are common obstructive lung diseases. It is important to differentiate 
between asthma, COPD, and other (lung) diseases to phenotype these diseases even if 
the asthma/COPD is not severe as well as to design individual care plans. International 
guidelines have suggested on the parameters that should be assessed to evaluate asthma 
and COPD.1–3 However, the guidelines do not provide suggestions on the additional 
tests that should be necessarily added to decrease the likelihood of other diagnoses, nor 
on the tests that should preferably be performed to identify treatable traits. A review 
showed that the use of care pathways results in a reduction of costs, improved quality 
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of life, reduced number of complications, increased patient 
satisfaction, improved communication between doctors and 
nurses, and reduced time that healthcare providers spent 
carrying out paperwork.4 However, for unknown reasons, a 
uniform international systematic approach for assessment of 
asthma and COPD patients referred to secondary care is lack-
ing. Therefore, a diagnostic approach has been developed for 
asthma and COPD patients in the Netherlands. This diagnostic 
approach includes functional tests in addition to additional 
tests to acquire detailed insights into symptoms, functional 
limitation, and quality of life, ultimately to create a personal-
ized treatment plan.5 Patients are involved in this treatment 
plan in formulating their own treatment goals. However, it 
is thought that patient involvement could be increased by the 
use of eHealth. The previous diagnostic approach has been 
successfully implemented. However, the effects of the use of 
this diagnostic approach on the number of diagnostics, final 
diagnoses, referrals back to primary care, and long-term out-
comes have not been evaluated yet. In addition, eHealth could 
be used as a method to integrate the individual care plans.6 
Therefore, in the LUMC, a novel systematic approach was 
developed that consisted of a predefined diagnostic evaluation 
combined with an optional internet-based self-management 
support system. Since March 2016, patients with (suspected) 
asthma or COPD who were referred by a GP to secondary 
pulmonary care were systematically evaluated with this sys-
tematic approach. The primary aim of this study was to deter-
mine whether there was a difference between the systematic 
approach and usual care in terms of type of diagnostic tests, 
number of diagnostic tests, final diagnosis, recorded lifestyle 
advices, symptoms and individual care plans in the electronic 
records, number of patients referred back to primary care, 
and time to referral back to primary care. The secondary 
aim of this study was to evaluate the number of patients who 
used the internet-based self-management support system. 
We hypothesize that a systematic approach could lead to a 
more specified diagnosis, more lifestyle advices, symptoms 
and individual care plans that are recorded in the electronic 
records, and more and faster referral back to primary care.
Materials and methods
Diagnostic pathway
Since March 2016, a novel systematic approach to evaluate 
patients with (suspected) asthma or COPD was released at 
the outpatient clinic of the department of pulmonology at 
the LUMC. A pulmonologist who was not involved in the 
study assessed the urge of the GP referrals. Patients with 
urgent complaints were scheduled at the outpatient clinic 
for acute respiratory complaints. The other patients were 
scheduled either within the novel systematic approach or 
by usual outpatient clinic care, depending on the first pos-
sibility at the outpatient clinic. With usual care, physicians 
decided which diagnostic tests to be performed based on 
outcomes of the clinical history and personal preferences. 
The systematic approach consisted of a predefined systematic 
diagnostic evaluation combined with an optional internet-
based self-management support system. There were two 
or three visits, or more if there was a medical reason for 
additional diagnostic tests (Figure 1). During the first visit, 
a nurse practitioner obtained general information, vital 
parameters, and evaluated inhaler technique. The same day, 
lung function tests (spirometry before and after broncho-
dilation and DLCO) were performed. Fe
NO
 was measured 
and a chest X-ray, ECG, and laboratory tests (including 
hemoglobin, erythrocyte sedimentation rate, white blood 
cell count with differential, sodium, potassium, creatinine, 
radioallergosorbent test, thyroid stimulating hormone, 
N-terminal pro B-type natriuretic peptide, total immuno-
globulin E, 25-hydroxyvitamin D, and alpha 1-antitrypsin) 
were performed. The nurse informed the patients about the 
internet-based self-management support system in the form 
of “PatientCoach”. PatientCoach has been developed by the 
LUMC specifically for patients with chronic diseases and con-
tains information about asthma and COPD, self-monitoring, 
an individual care plan, and e-visits.7 The GP can also access 
PatientCoach. If a patient agreed to use PatientCoach, he or 
she was asked to complete the Nijmegen Clinical Screening 
Instrument8 and asthma control questionnaire9 or the clinical 
COPD questionnaire10 at home. In addition, patients formu-
lated their own personal treatment goals. During the second 
visit, the nurse practitioner discussed the outcomes of the 
questionnaires and the personal goals. The second visit was 
canceled if the patients refused to use PatientCoach.
During the last planned visit, a pulmonologist or a pul-
monology resident discussed the outcomes of the diagnostic 
tests with the patient and an individual care plan was created. 
If a patient used PatientCoach, the individual care plan was 
integrated in PatientCoach. If additional diagnostic tests, 
eg, chest CT scan or sputum cultures, were needed, patients 
were scheduled for a fourth or later follow-up visit. If no 
more visits in the hospital were necessary, patients were 
referred back to primary care. The GP and the patient still 
had access to PatientCoach, enabling the continuation of 
eHealth in further care.
study design
This was a retrospective observational study of real-life data 
that were retrieved from the electronic record system of the 
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LUMC. Data were collected between November 2017 and 
January 2018 from patients who attended the outpatient 
clinic of the LUMC for the first time between March 2016 
and July 2017. The medical ethical committee of the LUMC 
waived the need for ethical approval due to the retrospective 
nature of the study. Consequently, the need for informed 
consent was not applicable.
study population
Patients were included if they were evaluated with the 
systematic approach or if they had a new record for asthma or 
COPD and were evaluated by usual outpatient clinic care. 
Patients were included if they attended the outpatient clinic 
of the LUMC for the first time between March 2016 and July 
2017. Patients were excluded if they attended the dyspnea 
clinic of the LUMC, if they had a previous record of asthma or 
COPD at the department of pulmonology at the LUMC, if 
they were solely admitted to the clinical ward; if they were 
not referred by a GP, if the first visit was at the emergency 
room or in the clinical ward, if the reason for referral was 
not asthma or COPD, or if the patient did not show up at the 
outpatient visits.
Data collection
Baseline characteristics were collected from the electronic 
records from the first visit at the department of pulmonology 
at the LUMC. Type of diagnostic tests, number of diagnos-
tic tests, final diagnosis, lifestyle advices, symptoms and 
Figure 1 novel systematic approach for asthma and COPD at the lUMC.
Abbreviations: eCg, electrocardiography; FenO, Fractional exhaled nitric oxide; lUMC, leiden University Medical Center.
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individual care plans in the electronic records, number of 
patients referred back to primary care, and time to referral 
back to primary care were collected from the electronic 
records as primary outcomes. The secondary outcome was 
the number of patients who used PatientCoach.
Diagnostic tests, needed for the work-up to the final 
diagnosis, were evaluated. The type of diagnostic tests that 
were assessed included laboratory tests, lung-specific labo-
ratory tests (including arterial blood gas analysis, alpha-1 
antitrypsin, and radioallergosorbent test), spirometry, 
histamine provocation test, Fe
NO
, DLCO, chest X-ray, CT 
(including pulmonary CT angiography), bronchoscopy, 
sputum cultures, six-minute walking test, and ECG. The 
final diagnosis that was registered in the electronic records 
was evaluated. Predefined diagnoses were asthma, COPD, 
a combination of asthma and COPD, another pulmonary 
disease, no pulmonary disease, obesity-related symptoms, 
or no diagnosis. If the final diagnosis was asthma and/or 
COPD, the phenotype was evaluated. Predefined phenotypes 
included allergic, nonallergic, late-onset asthma, asthma with 
fixed airflow limitation, and asthma with obesity.1 Alpha-1 
antitrypsin deficiency, emphysema/hyperinflation, and 
frequent exacerbators11 (including the GOLD group B and 
D2) were predefined phenotypes in COPD. The number of 
reported symptom scores, lifestyle advices, and individual 
care plans were collected from the electronic records. The 
number of patients who were referred back to primary care 
was collected. The number of days between referral and first 
visit, between first visit and final diagnosis, between first 
visit and the latest diagnostic test, and between first visit and 
referral back to primary care were calculated.
The number of patients who logged in at least once in 
PatientCoach was collected from the electronic records.
statistical analysis
Patients with missing data on the key variables were excluded 
(N=2). Descriptive data were reported as percentages and 
mean values±SD for continuous variables. To compare means 
between the systematic approach and usual care groups for 
continuous baseline characteristics as age and BMI, unpaired 
t-tests were used. To compare percentages between the 
systematic approach and usual care groups for categorical 
baseline characteristics as percentage women and smoking 
status, chi-squared tests were used. To compare percent-
ages of performed diagnostic tests between the systematic 
approach and usual care groups, chi-squared tests were used. 
To compare the mean time between referral and other time 
points and the mean number of performed diagnostic tests, 
between the systematic approach and usual care groups, 
unpaired t-tests were used. To compare percentages of final 
diagnosis as asthma and COPD, electronically recorded 
lifestyle advices, electronically recorded symptoms scores, 
electronically recorded individual care plans, and referrals 
back to primary care, between the systematic approach and 
usual care groups, chi-squared tests were used.
Since the use of PatientCoach was optional and a part of 
patients refused to use it, the number of patients who logged 
in at least once in PatientCoach was collected. The number 
of patients who logged in at least once in PatientCoach was 
expressed as percentage of the total number of patients who 
were included in the diagnostic approach. To compare means 
between patients in the systematic approach group who used 
PatientCoach and who did not for continuous baseline charac-
teristics, unpaired t-tests were used. To compare percentages 
between patients in the systematic approach group who used 
PatientCoach and who did not, for categorical baseline char-
acteristics, chi-squared tests were used. Furthermore, a sen-
sitivity analysis was performed to evaluate the differences in 
primary outcomes between the patients in the usual care and 
those in the diagnostic approach who used PatientCoach. All 
analysis were conducted using SPSS version 23.0.
Ethics statement
The medical ethical committee of the LUMC waived the need 
for ethical approval due to the retrospective nature of the study. 
Consequently, the need for informed consent was not applicable. 
Data that were entered in the database were de-identified.
Results
general outcomes
In total, 125 out of 608 patients were included in the analysis 
(Figure 2), of which 22 (21.4%) were evaluated with the 
systematic approach. Baseline characteristics of all included 
patients are presented in Table 1. In total, 67.2% of patients 
were referred for asthma. Mean (±SD) age was 48.8 (±18.4) 
years and 59.2% of patients were women. There were no 
significant differences in baseline characteristics between 
patients who were evaluated with the systematic approach 
compared with usual care.
Diagnostic tests
The most frequently performed diagnostic test was spirometry 
(97.6%) (Table 2). The mean (±SD) number of diagnostic 
tests was significantly higher in the systematic approach group 
compared with the usual care group (7.6±1.0 vs 5.5±1.8). 
Laboratory tests, lung-specific laboratory tests, Fe
NO
, DLCO, 
chest X-rays, and ECG were more frequently performed in the 
systematic approach group than in the usual care group.
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Final diagnosis and registered symptom 
scores, lifestyle advices, and individual 
care plans
Most patients were finally diagnosed with asthma (53.6%), 
COPD (25.6%), or no pulmonary disease (9.8%). There were 
no differences in final diagnosis and phenotypes between the 
systematic approach and usual care groups (Table 3). In the 
systematic approach group, more lifestyle advices (81.8% vs 
29.1%), symptom scores (95.5% vs 21.4%), and individual 
care plans (50.0% vs 7.8%) were electronically registered 
compared with the usual care group (all P,0.001).
Time to final diagnosis and referral back 
to primary care
There were differences in the number of days between refer-
ral and first visit (difference 4.4 days), between first visit and 
latest diagnostic test (difference 22.7 days), and between 
first visit and final diagnosis (difference 34.1 days) between 
the systematic approach and usual care groups. However, 
these differences did not reach significance (Table 4). More 
patients in the systematic approach group were referred back 
to primary care compared with the usual care group (81.8% 
vs 56.3%, P=0.03).
Use of PatientCoach
In the systematic approach group, 14 out of 22 patients 
(63.6%) logged in at least once on PatientCoach. Patients 
who used PatientCoach were significantly younger and had 
less cardiovascular comorbidities than those who did not use 
PatientCoach. Reasons to refuse the use of PatientCoach were 
not having a computer (N=2), lack of computer skills (N=4), 
definitely no desire to use PatientCoach without a further rea-
son (N=1), and for one patient the reason was not applicable.
Figure 2 Flow diagram.
Abbreviations: gP, general practitioner; lUMC, leiden University Medical Center.
Total number of patients (N=608)
N=125 patients included in analyses
30 patients in the
care pathway
asthma/COPD
N=24
patients
N=22
patients
N=103
patients
Meet exclusion criteria
–  Attended the dyspnea
    clinic (N=32)
–  Previous record at the
    LUMC (N=100)
–  No outpatient clinic visit
    (N=48)
–  Not referred by GP
    (N=224)
–  Reason of referral
    other than asthma or
    COPD (N=56)
Missing data
–  No show at outpatient
    clinic (N=13)
–  Height (N=2)
Meet exclusion criteria
–  Not referred by GP
    (N=4)
–  Reason of referral
    other than asthma or
    COPD (N=2)
Missing data
–  No show at
    outpatient clinic
    (N=2)
N=118
patients
578 patients with a
new record for
asthma or COPD
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sensitivity analysis
After removing eight patients who attended the systematic 
approach, but refused the use of PatientCoach, the statistically 
significant differences between the systematic approach and 
usual care were still present (Tables S1 and S2).
Discussion
This study was conducted to evaluate a systematic approach 
combined with an optional internet-based self-management 
support system for asthma and COPD patients referred to 
secondary care. In the systematic approach group compared 
with the usual care group, mean number of diagnostic tests 
was higher; more lifestyle advices, symptom scores, and 
individual care plans were electronically recorded; and more 
patients were referred back to primary care. There were no 
differences in final diagnosis and time to referral back. More 
than half of patients were interested in an internet-based self-
management support system when it was offered in addition 
to a systematic approach.
To our knowledge, this is the first study that evaluated a 
systematic approach in combination with an optional internet-
based self-management support system as a method to 
Table 1 Baseline characteristics
Characteristics Total 
group 
(N=125)
Usual care
(N=103)
Systematic 
approach
(N=22)
Difference
(P-value)
age in years (mean, sD) 48.8 (18.4) 48.2 (18.2) 51.8 (19.5) 0.41
sex, n (% women) 74 (59.2) 58 (56.3) 16 (72.7) 0.16
BMI in kg/m² (mean, sD) 27.0 (6.8) 26.7 (6.7) 28.2 (7.6) 0.37
Cardiovascular comorbidities, n (% yes) 28 (22.4) 23 (22.3) 5 (22.7) 0.97
reason of referral, n (% asthma) 84 (67.2) 69 (67.0) 15 (68.2) 0.91
smoker status
never smoker, n (% yes) 55 (44.0) 43 (41.7) 12 (54.5) 0.27
Former smoking, n (% yes) 44 (35.2) 39 (37.9) 5 (22.7) 0.18
Current smoker, n (% yes) 26 (20.8) 21 (20.4) 5 (22.7) 0.81
Medication use at baseline
saBa, n (% yes) 73 (58.4) 57 (55.3) 16 (72.7) 0.13
laBa, n (% yes) 79 (63.2) 63 (61.2) 16 (72.7) 0.31
saMa, n (% yes) 16 (12.8) 14 (13.6) 2 (9.1) 0.57
laMa, n (% yes) 29 (23.2) 23 (22.3) 6 (27.3) 0.62
ICs, n (% yes) 90 (72.0) 73 (70.9) 17 (77.3) 0.54
lTra, n (% yes) 9 (7.2) 6 (5.8) 3 (13.6) 0.20
antihistamines, n (% yes) 36 (28.8) 28 (27.2) 8 (36.4) 0.39
Abbreviations: ICs, inhaled corticosteroids; laBa, long-acting beta2-agonist; laMa, long-acting muscarinic-antagonist; lTra, leukotriene receptor antagonist; saBa, 
short-acting beta2-agonist; saMa, short-acting muscarinic-antagonist.
Table 2 Diagnostic tests at the outpatient clinic for the evaluation of asthma and COPD
Diagnostic tests Total 
group
(N=125)
Usual care 
(N=103)
Systematic 
approach
(N=22)
Difference
(P-value)
laboratory tests, n (% yes) 108 (86.4) 86 (83.5) 22 (100.0) 0.040
Lung-specific laboratory tests, n (% yes) 100 (80.0) 79 (76.7) 21 (95.5) 0.046
spirometry, n (% yes) 122 (97.6) 100 (97.1) 22 (100.0) 0.42
histamine provocation test, n (% yes) 40 (32.0) 34 (33.0) 6 (27.3) 0.60
FenO, n (% yes) 85 (68.0) 64 (62.1) 21 (95.5) 0.002
DlCO, n (% yes) 88 (70.4) 66 (64.1) 22 (100.0) 0.001
Chest X-ray, n (% yes) 97 (77.6) 76 (73.8) 21 (95.5) 0.027
Chest CT scan, n (% yes) 23 (18.4) 18 (17.5) 5 (22.7) 0.56
Bronchoscopy, n (% yes) 1 (0.8) 1 (1.0) 0 (0.0) 0.64
sputum cultures, n (% yes) 46 (19.2) 18 (17.5) 6 (27.3) 0.29
six-minute walking test, n (% yes) 1 (0.8) 1 (1.0) 0 (0.0) 0.64
eCg, n (% yes) 38 (30.4) 18 (17.5) 20 (90.9) ,0.001
number of diagnostic tests (mean, sD) 5.8 (1.9) 5.5 (1.8) 7.6 (1.0) ,0.001
Notes: Bold values indicate statistical significance.
Abbreviations: CT, computed tomography; DlCO, diffusing capacity for carbon monoxide; eCg, electrocardiography; FenO, fractional exhaled nitric oxide.
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evaluate diagnosis and symptoms and to integrate individual 
care plans in secondary care pulmonology. More diagnostic 
tests were performed in the systematic approach compared 
to usual care in the present study. This could be expected 
since the diagnostic approach consisted of more diagnostic 
tests than are stated in the guidelines. Since there were no 
differences in the final diagnoses made by pulmonologists 
and the process was not faster, this suggests that not all tests 
included in the systematic approach are regularly needed 
in the diagnostic work-up. In another systematic approach 
that has been developed for asthma and COPD patients in 
the Netherlands, other standard diagnostic tests were used: 
capillary blood gas analyses, metronome-paced hyperventila-
tion test, and physical activity assessment by accelerometry 
were performed in all patients; X-rays, Fe
NO
, and allergic 
assessment were performed only in selected patients.5 Taking 
the results of the present study and the previous Delphi 
study into account, it can be suggested that lung-specific 
laboratory tests, DLCO, X-rays, Fe
NO
, and an ECG should 
preferably be performed on indication and should not be 
included in a systematic approach in nonselected patients, 
since these additional tests did not lead to other diagnoses. 
This decision will decrease the number of diagnostic tests 
and thereby costs. On the other hand, it is possible that the 
additional diagnostic tests contributed more certainty to a 
diagnoses of asthma or COPD, resulting in more referrals 
back to primary care, as observed in our study. This follows 
the Dutch guidelines to refer patients back to primary care 
Table 3 Final diagnosis, phenotypes, and treatment plans in the diagnostic pathway compared with usual care
Final diagnosis and treatment Total 
group 
(N=125)
Usual care 
(N=103)
Systematic 
approach 
(N=22)
Difference 
(P-value)
Final diagnosis
asthma, n (%) 67 (53.6) 56 (54.4) 11 (50.0) 0.71
Phenotyped, n (% yes) 57 (85.1) 46 (82.1) 11 (100.0) 0.13
allergic asthma,a n (% yes) 44 (65.7) 35 (62.5) 9 (81.8) 0.22
nonallergic asthma,a n (% yes) 11 (16.4) 9 (16.1) 2 (18.2) 0.86
late-onset,a n (% yes) 7 (10.4) 6 (10.7) 1 (9.1) 0.87
With fixed airflow limitation,a n (% yes) 4 (6.0) 4 (7.1) 0 (0.0) 0.36
asthma with obesity,a n (% yes) 0 (0.0) 0 (0.0) 0 (0.0) na
COPD, n (%) 32 (25.6) 27 (26.2) 5 (22.7) 0.73
Phenotyped, n (% yes) 18 (56.3) 16 (59.3) 2 (40.0) 0.43
AAT deficiency,a n (% yes) 0 (0.0) 0 (0.0) 0 (0.0) na
Emphysema/hyperinflation,a n (% yes) 6 (18.8) 6 (22.2) 0 (0.0) 0.24
Frequent exacerbations,a n (% yes) 12 (37.5) 10 (37.0) 2 (40.0) 0.90
Combination of asthma and COPD, n (%) 1 (0.8) 1 (1.0) 0 (0.0) 0.64
Phenotyped, n (% yes) 1 (100.0) 1 (100.0) 0 (0.0) na
Other pulmonary disease, n (% yes) 6 (4.8) 4 (3.9) 2 (9.1) 0.30
no pulmonary disease, n (% yes) 12 (9.6) 10 (9.7) 2 (9.1) 0.93
Obesity-related symptoms, n (% yes) 3 (2.4) 2 (1.9) 1 (4.5) 0.47
no diagnosis, n (% yes) 2 (1.6) 2 (1.9) 0 (0.0) 0.51
lifestyle advices, n (% yes) 48 (38.4) 30 (29.1) 18 (81.8) ,0.001
symptom scores, n (% yes) 43 (34.4) 22 (21.4) 21 (95.5) ,0.001
Individual care plans, n (% yes) 19 (15.2) 8 (7.8) 11 (50.0) ,0.001
Notes: aPatients could be categorized in more than one phenotype. Bold values indicate statistical significance.
Abbreviation: aaT, alpha 1-antitrypsin.
Table 4 Time between referral, first visit, final diagnosis, latest diagnostic test, and referral back to primary care
Time Total 
group 
(N=125)
Usual care 
(N=103)
Systematic 
approach 
(N=22)
Difference 
(P-value)
From referral to first visit in days (mean, SD) 37.7 (23.6) 38.4 (24.6) 34.0 (17.8) 0.43
From first visit to final diagnosis in days (mean, SD) 68.3 (88.0) 72.3 (91.7) 49.6 (66.9) 0.28
From first visit to latest diagnostic test in days (mean, SD) 116.7 (127.3) 122.7 (128.7) 88.6 (119.2) 0.26
referred back to primary care, n (%) 76 (60.8) 58 (56.3) 18 (81.8) 0.03
Time from first visit and referral to primary care in days (mean, SD) 114.1 (97.7) 113.3 (96.0) 116.5 (105.8) 0.91
Note: Bold values indicate statistical significance.
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when the diagnostic work-up is completed and patients are 
clinically stable.12 Another explanation of more referrals back 
to primary care might be the higher number of written care 
plans, since pulmonologists might believe that the care plans 
will support the GP and patients in the continuation of care. 
The present study shows that if physicians are directed to 
register individual care plans, this was done more frequently 
than with usual care. This is in line with a systematic 
review that the use of clinical pathways results in improved 
documentation.13 We think that more than 48.5% of patients 
in the usual care group did receive lifestyle advices and 
individual care plans, but these advises were given verbally 
and were not necessarily registered in the medical records. 
However, international guidelines recommend written care 
plans and not solely spoken arrangements.1,2 A designated 
pathway within an outpatient clinic could thus add to improve 
registration of individual care plans.
The internet-based self-management support system was 
accepted by 63.6% of patients, which is in line with a previ-
ous study that showed that 63% of patients would definitely 
or probably use an eHealth application if it was offered.14 
In the present study, reasons to refuse eHealth were mostly 
computer (skill) related. A previous study showed that patients 
who do not use eHealth do not recognize the advantages of 
eHealth and should be convinced first.15 Patients who do have 
experience with the use of eHealth are positive.15 The use of 
PatientCoach may be lower than 63.6%, because only the first 
login was evaluated, and it is known from previous research 
that some patients stop using the application.16 Probably, more 
patients would use PatientCoach when previously determined 
barriers such as sufficient functionalities to tailor PatientCoach 
and personal guidance are further optimized.17 An advantage 
of the use of eHealth is that patients considered eHealth as a 
possibility to take more responsibility in their own care.15
A strength of the present study was that the outcomes 
seem to be generalizable to all asthma and COPD patients 
referred to secondary care since we included nonselected 
patients and not only severe asthma and COPD patients. 
For difficult to manage asthma, systematic approaches 
exist18,19 with positive effects on asthma control, quality 
of life, and exacerbation frequency.19 However, the results 
are only applicable for ,15% of all asthma patients.20 Care 
pathways for in-hospital management of exacerbated COPD 
exist, with positive effects on 30-day readmission rate.21 The 
present study shows that a systematic approach seems to 
be beneficial for all patients with asthma as well as COPD 
referred to secondary care pulmonology. However, we based 
our conclusions on a limited number of patients who were 
evaluated with the systematic approach. However, there 
were no differences in baseline characteristics compared 
with the usual care group that consisted of 103 patients. 
A limitation of the present study is the possibility of bias 
during the selection process whether patients were evaluated 
with the systematic approach or with usual care. This could 
have led to patients with less severe disease in the systematic 
approach since patients with acute complaints were evalu-
ated at the outpatient clinic for acute respiratory complaints. 
However, there were no differences in the number of days 
between referral and first visit, suggesting that a limited 
number of patients within the usual care group were referred 
for acute respiratory complaints. Another limitation is that 
the data were retrieved from only one university hospital. 
This could have resulted in more complex disease combined 
with comorbidities. Consequently, the results could be less 
generalizable to local hospitals. However, in this study 
only patients who were referred by the GP were included 
and those who were referred for second or third opinion 
were excluded. A third limitation is that patients who were 
evaluated with the systematic approach were evaluated by 
a limited number of pulmonologists, whereas the patients 
who received usual care were seen by multiple pulmonolo-
gists of the department. We do not think this affected the 
results, since all patients in the systematic approach group 
were systematically evaluated and the pulmonologist could 
not influence the standard diagnostic tests, whereas in the 
usual care group, the diversity of physicians reduces the 
possibility of a physician-dependent preference for diag-
nostic work-up.
Giving the results of the present study, we recommend 
the use of systematic approaches that direct physicians to 
register lifestyle advices, symptoms, and individual care 
plans in daily practice, with a limited number of standard 
diagnostic tests. We recommend prospective evaluation of 
the impact of this systematic approach on disease control, 
quality of life, lifestyle changes, and costs.
Conclusion
A predefined systematic approach in combination with an 
optional internet-based self-management support system is 
useful in clinical practice. Since there were no differences in 
the final diagnoses, this suggests that not all tests that were 
included in the systematic approach are regularly needed in 
the diagnostic work-up. The outcomes suggest that a desig-
nated systematic approach stimulates physicians to record 
lifestyle advices, symptoms, and individual care plans. 
Subsequently, this approach could increase the number of 
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patients referred back to primary care, according to national 
healthcare guidelines in the Netherlands.
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Table S1 Final diagnosis, phenotypes, and treatment plans in the diagnostic pathway compared to usual care
Final diagnosis and treatment Total 
group
(N=117)
Usual care 
(N=103)
Systematic 
approach
(N=14)
Difference
(P-value)
Final diagnosis 
asthma, n (%) 65 (55.6) 56 (54.4) 9 (64.3) 0.48
Phenotyped, n (% yes) 55 (84.6) 46 (82.1) 9 (100) 0.17
allergic asthma,* n (% yes) 43 (66.2) 35 (62.5) 8 (88.9) 0.12
nonallergic asthma,* n (% yes) 10 (15.4) 9 (16.1) 1 (11.1) 0.70
late-onset,* n (% yes) 6 (9.2) 6 (10.7) 0 (0.0) 0.30
With fixed airflow limitation,* n (% yes) 4 (6.2) 4 (7.1) 0 (0.0) 0.41
asthma with obesity,* n (% yes) 0 (0.0) 0 (0.0) 0 (0.0) na
COPD, n (%) 29 (24.8) 27 (26.2) 2 (14.3) 0.33
Phenotyped, n (% yes) 17 (58.6) 16 (59.3) 1 (50.0) 0.80
AAT deficiency,* n (% yes) 0 (0.0) 0 (0.0) 0 (0.0) na
Emphysema/hyperinflation,* n (% yes) 6 (20.7) 6 (22.2) 0 (0.0) 0.45
Frequent exacerbations,* n (% yes) 11 (37.9) 10 (37.0) 1 (50.0) 0.72
Combination of asthma and COPD, n (%) 1 (0.9) 1 (1.0) 0 (0.0) 0.71
Phenotyped, n (% yes) 1 (100) 1 (100) 0 (0.0) na
Other pulmonary disease, n (% yes) 5 (4.3) 4 (3.9) 1 (7.1) 0.57
no pulmonary disease, n (% yes) 11 (9.4) 10 (9.7) 1 (7.1) 0.76
Obesity-related symptoms, n (% yes) 2 (1.7) 2 (1.9) 0 (0.0) 0.60
no diagnosis, n (% yes) 2 (1.7) 2 (1.9) 0 (0.0) 0.60
lifestyle advices, n (% yes) 43 (36.8) 30 (29.1) 13 (92.9) ,0.001
symptom scores, n (% yes) 36 (30.8) 22 (21.4) 14 (100) ,0.001
Individual care plans, n (% yes) 16 (13.7) 8 (7.8) 8 (57.1) ,0.001
Notes: *Patients could be categorized into more than one phenotype. Bold values indicate statistical significance.
Abbreviation: aaT, alpha 1-antitrypsin.
Table S2 Time between referral, first visit, final diagnosis, latest diagnostic test, and referral back to primary care
Time Total 
group
(N=117)
Usual care 
(N=103)
Systematic 
approach
(N=14)
Difference
(P-value)
From referral to first visit in days (mean, SD) 37.7 (23.7) 38.4 (24.6) 32.1 (14.1) 0.35
From first visit to final diagnosis in days (mean, SD) 69.6 (89.3) 72.3 (91.7) 49.7 (69.4) 0.38
From first visit to latest diagnostic test in days (mean, SD) 119.3 (128.3) 122.7 (128.7) 94.0 (127.0) 0.43
referred back to primary care, n (%) 70 (59.8) 58 (56.3) 12 (85.7) 0.04
Time from first visit and referral to primary care in days (mean, SD) 117.5 (97.9) 113.3 (96.0) 137.7 (108.6) 0.44
Note: Bold values indicate statistical significance.
Supplementary materials
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